Neogenomics Stock Alpha and Beta Analysis
| NEO Stock | USD 18.25 0.08 0.44% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NeoGenomics. It also helps investors analyze the systematic and unsystematic risks associated with investing in NeoGenomics over a specified time horizon. Remember, high NeoGenomics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NeoGenomics' market risk premium analysis include:
Beta 1.25 | Alpha 0.11 | Risk 2.57 | Sharpe Ratio 0.0759 | Expected Return 0.2 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
NeoGenomics |
NeoGenomics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NeoGenomics market risk premium is the additional return an investor will receive from holding NeoGenomics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NeoGenomics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NeoGenomics' performance over market.| α | 0.11 | β | 1.25 |
NeoGenomics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of NeoGenomics' Buy-and-hold return. Our buy-and-hold chart shows how NeoGenomics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.NeoGenomics Market Price Analysis
Market price analysis indicators help investors to evaluate how NeoGenomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeoGenomics shares will generate the highest return on investment. By understating and applying NeoGenomics stock market price indicators, traders can identify NeoGenomics position entry and exit signals to maximize returns.
NeoGenomics Return and Market Media
The median price of NeoGenomics for the period between Fri, Sep 13, 2024 and Thu, Dec 12, 2024 is 15.36 with a coefficient of variation of 10.43. The daily time series for the period is distributed with a sample standard deviation of 1.59, arithmetic mean of 15.28, and mean deviation of 1.37. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 | 10/15/2024 |
2 | NeoGenomics Inc Shares Up 4.16 percent on Nov 1 | 11/01/2024 |
3 | NeoGenomics, Inc. Q3 2024 Earnings Call Transcript | 11/07/2024 |
4 | Disposition of 11336 shares by Hannah Alison L. of NeoGenomics subject to Rule 16b-3 | 11/15/2024 |
5 | NeoGenomics general counsel sells 79,475 in stock | 11/19/2024 |
6 | Segall Bryant Hamill LLC Has 27.93 Million Holdings in NeoGenomics, Inc. | 11/20/2024 |
7 | NeoGenomics Inc Shares Up 4.09 percent on Nov 22 | 11/22/2024 |
8 | NEO Battery Materials Announces Corporate Webinar on Silicon Anode Technology Developments Pathway to Commercialization | 11/25/2024 |
9 | Disposition of 6224 shares by Warren Stone of NeoGenomics subject to Rule 16b-3 | 11/29/2024 |
10 | NEO SPACE GROUP TO ACQUIRE UP42 EARTH OBSERVATION DIGITAL PLATFORM FROM AIRBUS | 12/03/2024 |
11 | Brokerages Set NeoGenomics, Inc. PT at 20.25 | 12/05/2024 |
12 | Disposition of 11746 shares by Sherman Jeffrey Scott of NeoGenomics subject to Rule 16b-3 | 12/06/2024 |
13 | NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting | 12/09/2024 |
About NeoGenomics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NeoGenomics or other stocks. Alpha measures the amount that position in NeoGenomics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 85.72 | 80.96 | 70.22 | PTB Ratio | 1.15 | 2.16 | 2.05 |
NeoGenomics Upcoming Company Events
As portrayed in its financial statements, the presentation of NeoGenomics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NeoGenomics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of NeoGenomics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of NeoGenomics. Please utilize our Beneish M Score to check the likelihood of NeoGenomics' management manipulating its earnings.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with NeoGenomics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out NeoGenomics Backtesting, NeoGenomics Valuation, NeoGenomics Correlation, NeoGenomics Hype Analysis, NeoGenomics Volatility, NeoGenomics History and analyze NeoGenomics Performance. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
NeoGenomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.